Long-term, sustained efficacy and safety from a phase 1/2 clinical trial of an AAV8-mediated liver-directed gene therapy in adults with glycogen ...
https://www.google.com/url?rct=j&sa=t&url=https://www.kulr8.com/news/money/ultragenyx-reports-fourth-quarter-and-full-year-2021-financial-results-and-corporate-update/article_9f3115cb-0551-5ef2-bc68-7cc2ff50d69d.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGkvwgV5CDURydLIGBaAs0FQd68Rg
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.